Medicare Advantage enrollment has crossed 33 million members, and the pressure on health plans to capture accurate risk scores has never been higher. The stakes are straightforward: incomplete documentation means understated risk scores, and understated risk scores mean reimbursement that doesn't match actual patient acuity.
The companies in this space have changed significantly over the past few years. Manual chart review processes that once took 40 or more minutes per record are being replaced by AI-driven platforms that complete the same work in under 10 minutes at higher accuracy rates. Choosing the right partner in this environment is a financial and compliance decision that compounds over time.
Key Takeaways
- CMS now calculates 100% of Medicare Advantage risk scores using the V28 model. This regulatory shift took full effect January 1, 2026, and changes how health plans must approach HCC documentation.
- AI explainability is no longer optional. Platforms that can't show their reasoning behind each HCC recommendation create audit exposure rather than reducing it.
- Coding accuracy above 98% is the benchmark. Leading platforms are hitting this threshold consistently. Anything lower represents unacceptable risk at scale.
- Chart review time reduction of 60 to 80% is achievable. The best platforms cut manual workload dramatically while improving, not just maintaining, accuracy.
- The fastest risk adjustment platforms close documentation gaps before submission deadlines rather than after.
- Vendor selection should be based on verifiable metrics. Ask for documented accuracy rates, client outcomes, and audit performance before committing to a partner.
What Risk Adjustment Companies Actually Do
Risk adjustment isn't just about coding. It's about ensuring that a patient's full disease burden is accurately reflected in the documentation submitted to CMS, so that the reimbursement a health plan receives matches the actual cost of caring for that member population.
When done well, the process protects financial sustainability and enables better care coordination. When done poorly, it creates compliance exposure, revenue loss, and the kind of last-minute audit surprises that no risk team wants to manage.
The technology gap between the leading platforms and everyone else has widened considerably. Evaluating the top risk adjustment companies in the market today means understanding not just what they claim but what they can demonstrate, in coding accuracy, chart review speed, audit readiness.
For a broader view of how AI is reshaping healthcare operations across the industry, our healthcare technology overview covers the key trends worth watching alongside risk adjustment.
The Best Risk Adjustment Companies Ranked
1. RAAPID
RAAPID stands apart from every other platform on this list by being the first risk adjustment company to deploy Neuro-Symbolic AI at scale. That distinction matters more than it might initially appear.
Most AI systems in this space operate as opaque models. They produce outputs without explaining the clinical reasoning behind them. In risk adjustment, where every HCC submission is subject to CMS scrutiny and RADV audit risk, an AI that can't show its work isn't actually reducing compliance exposure. It's shifting it.
RAAPID's Neuro-Symbolic architecture solves this directly. It combines neural network pattern recognition with symbolic clinical reasoning, meaning the system identifies suspected diagnoses from unstructured clinical notes and then validates each finding against MEAT criteria (Monitoring, Evaluating, Assessing, Treating) with a fully traceable evidence trail. Every HCC code comes with documented justification linking back to specific data in the medical record.
The platform delivers 98%+ coding accuracy, reduces chart review time by 60 to 80%, and covers both retrospective and prospective risk adjustment workflows under one roof. It is HITRUST certified and has received Series A funding from a strategic investment group that spans the health plan, provider, and technology sectors.
For health plans preparing for RADV audits or operating under the full V28 model environment, RAAPID's audit-ready output and explainable AI infrastructure represent a meaningful operational advantage over platforms that produce codes without clinical reasoning trails.
Best for: Health plans and providers that need explainable AI, high coding accuracy, and audit-ready HCC documentation under the V28 regulatory framework.
2. Cotiviti
Cotiviti operates at considerable scale, serving more than 200 health plans including all of the top 25. The company processes billions of clinical and financial records annually, combining advanced analytics with healthcare expertise across Medicare Advantage, commercial, and Medicaid lines.
The platform uses natural language processing for medical records review and supports payment accuracy and quality programs alongside risk adjustment coding. Cotiviti's 2025 acquisition of Edifecs expanded its interoperability capabilities, giving health plans stronger data connectivity across their existing technology environments.
With 25 or more years of service delivery and a client base that includes most major national payers, Cotiviti brings institutional stability and deep domain expertise. The tradeoff is that large enterprise platforms can be slower to adapt to specific client needs compared to more specialized providers.
Best for: Large national health plans that need a stable, enterprise-grade analytics partner with broad program coverage across multiple lines of business.
3. Inovalon
Inovalon's ONE Platform takes a cloud-based approach to risk adjustment, combining national-scale data access with predictive analytics to identify risk gaps across member populations. The platform has processed more than 85 billion medical events and covers analytics across 395 million unique lives.
In late 2024, Inovalon launched its AI-powered Converged Record Review capability, which uses algorithms to analyze patient data and reduce unnecessary manual medical records review by up to 50%. The predictive modeling layer helps health plans identify suspected diagnoses earlier in the documentation cycle rather than recovering them retrospectively.
The platform's strength is its data breadth. Access to population-level analytics at Inovalon's scale enables pattern recognition that smaller datasets simply can't support. For health plans with large, geographically distributed member populations, that data advantage is meaningful.
Best for: Health plans that prioritize predictive analytics and population-level risk identification across diverse member demographics.
4. Reveleer
Reveleer focuses specifically on the value-based care segment, offering a platform that covers risk adjustment coding, quality improvement, clinical intelligence, and member management within a single workflow environment. The company serves more than 70 health plans covering 66 million lives.
In 2024 alone, Reveleer processed 1.1 billion pages of medical records and delivered 2.5 million diagnoses, with the company claiming accuracy rates of up to 99%. Workflow automation within the platform reduces review time by more than 40%, and the system supports both prospective coding at the point of care and retrospective chart review.
The company raised over $65 million in 2024 funding, signaling investor confidence in its trajectory. For health plans operating in value-based care arrangements where quality program performance ties directly to financial outcomes, Reveleer's integrated approach reduces the number of vendors needed to manage the full risk adjustment and quality cycle.
Best for: Health plans in value-based care models that want integrated risk adjustment and quality improvement capabilities within a single platform.
5. Episource
Episource has built a strong reputation as a full-service risk adjustment partner, combining technology with a large team of certified risk adjustment coders. The company serves Medicare Advantage, ACA, and Medicaid health plans and covers both retrospective and prospective programs.
What differentiates Episource is its hybrid model. Rather than relying solely on automated AI output, the platform combines machine-assisted review with human coder oversight. For health plans that want a higher degree of human review in their QA process, this model provides a different risk profile than fully automated alternatives.
The company also offers member engagement services, including health assessments and in-home evaluations, which create additional opportunities to identify and document diagnoses prospectively before the submission window closes.
Best for: Health plans that prefer a hybrid AI-plus-human coding model and want member engagement services bundled with their risk adjustment program.
How to Choose the Right Partner
The evaluation process matters as much as the shortlist. Every vendor in this space will cite strong accuracy numbers and impressive processing volumes. The question is how they support those claims.
Ask for client references in health plans of similar size and complexity to yours. Request documentation of audit outcomes on RADV reviews. Understand exactly what "accuracy" means in their measurement methodology, because the denominator matters as much as the numerator.
Explainability should be a non-negotiable evaluation criterion in the current regulatory environment. If a platform cannot demonstrate a traceable evidence trail from clinical data to HCC code, it cannot protect a health plan during an audit. That's not a feature gap. It's a compliance gap.
Conclusion
The risk adjustment technology market has matured quickly, and the performance gap between leading platforms and legacy approaches is significant and growing. Health plans that choose the right partner now position themselves to capture accurate reimbursement, manage audit risk, and build documentation practices that hold up as CMS regulatory standards continue to evolve.
The companies on this list represent the strongest options across different organizational needs and priorities. RAAPID leads on explainable AI and audit readiness, Cotiviti and Inovalon offer enterprise scale, Reveleer integrates value-based care quality programs, and Episource provides a hybrid approach for plans that want human oversight in the loop.
The right choice depends on where your organization is today and where the regulatory environment is heading. Both are moving targets, and the platform you choose should be built to keep pace with both.
FAQ
What is risk adjustment in Medicare Advantage?
Risk adjustment is the process by which CMS calculates risk scores based on documented patient diagnoses to predict expected healthcare costs for each member. Health plans receive higher reimbursement for members with more complex conditions, which is why accurate and complete HCC coding directly affects financial performance.
What changed with the CMS-HCC V28 model?
The V28 model updates the diagnosis categories and risk score calculations that CMS uses for Medicare Advantage reimbursement. Starting January 1, 2026, CMS calculates 100% of MA risk scores using V28, completing a three-year phase-in. Health plans need technology partners that have updated their coding logic to align with the new model.
What is Neuro-Symbolic AI and why does it matter for risk adjustment?
Neuro-Symbolic AI combines neural network pattern recognition with symbolic reasoning grounded in clinical rules. Unlike standard AI models that produce outputs without explaining their reasoning, neuro-symbolic systems provide traceable evidence trails linking each HCC recommendation to specific clinical data. This explainability is critical for audit readiness.
What is the difference between retrospective and prospective risk adjustment?
Retrospective risk adjustment reviews historical medical records after care has been delivered to identify missed or underdocumented diagnoses. Prospective risk adjustment works at the point of care, capturing diagnoses during patient encounters when clinical data is most complete. The best platforms support both workflows.
How do I evaluate a risk adjustment vendor's accuracy claims?
Ask vendors for third-party validated accuracy rates, not self-reported figures. Request documentation of coding accuracy across a representative sample of chart types, and ask specifically how they measure and define accuracy. Also ask about audit outcomes from RADV reviews to understand how their documentation holds up under CMS scrutiny.
What is MEAT criteria and why does it matter?
MEAT stands for Monitoring, Evaluating, Assessing, and Treating. CMS requires that each submitted diagnosis be supported by clinical evidence showing that the condition is actively being addressed. Platforms that automatically capture MEAT-based evidence for each HCC produce documentation that is far more defensible during audits than platforms that simply flag potential diagnoses.
